Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

NCT07302802 is registered in ClinicalTrials.gov with Prof. Dr. Martin Wabitsch as lead sponsor.

NCT NCT07302802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07302802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice
Lead sponsor
Prof. Dr. Martin Wabitsch
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2025
Completion date
December 31, 2028
Enrollment
70 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

monogenic obesity